Li Ou (2025) “TNFRSF1B-DRIVEN MYELOID PLASTICITY CONSTITUTES A CLINICALLY TRACTABLE IMMUNOSUPPRESSIVE AXIS ACROSS HUMAN CANCERS”, LIFE: International Journal of Health and Life-Sciences, pp. 65–66. doi: 10.20319/icrlsh.2025.6566.